Press Releases
Recro Pharma Reports Third Quarter 2017 Financial Results
Recro Pharma to Present at Upcoming Investor Conferences
Recro Pharma Reports Inducement Grants for New Staff
Recro Pharma Presents Phase III IV Meloxicam Clinical Efficacy Data in Patients Following Abdominoplasty at the 2017 American Society of Plastic Surgeons Annual Meeting
Recro Pharma to Participate in Upcoming Investor Conferences
Recro Pharma Announces PDUFA Date for IV Meloxicam 30mg
Recro Pharma Reports Inducement Grants for New Staff
Recro Pharma Announces FDA Acceptance for Review of New Drug Application for IV Meloxicam 30mg
Recro Pharma Presents Phase III IV Meloxicam Clinical Safety and Opioid Use Data at PAINWeek® 2017
